Hepatic fascioliasis: case report and review Fasciolíase hepática. Relato de um caso e revisão da literatura

A well documented case of hepatic fascioliasis (HF), successfully treated with triclabendazole, is reported. Predominant clinical manifestations were fever, marked eosinophilia and abdominal pain. Triclabendazole was given as two single oral doses of 10 mg/kg each. Neither side effects nor clinical...

Full description

Bibliographic Details
Published in:	Revista do Instituto de Medicina Tropical de São Paulo
Main Authors:	Salha Abdul-Hadi, Rosa Contretas, Claudio Tombazzi, Marta Alvarez, Maribel Melendez
Format:	Article
Language:	English
Published:	Universidade de São Paulo (USP) 1996-02-01
Subjects:	Fasciola hepatica Hepatic fascioliasis Eosinophilia Triclabendazole
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46651996000100013

Similar Items

Evaluation of patients diagnosed with fascioliasis: A six-year experience at a university hospital in Turkey
by: Vuslat Keçik Boşnak, et al.
Published: (2016-04-01)

Successful Treatment of Fasciola hepatica with Metronidazole in a Child: A Case Report
by: Zeynep Ergenc, et al.
Published: (2022-12-01)

Fasciola hepatica Diagnosis: Clinical and Laboratory Clues from A University Hospital Experience
by: Ayşe Sağmak Tartar, et al.
Published: (2025-06-01)

Hepatic fascioliasis: report of a patient
by: Néstor E. Vega Alonso, et al.
Published: (2013-10-01)

Spontaneous hepatic hemorrhage in fascioliasis: Imaging and diagnostic challenges in a rare case series from East Africa
by: Semira Abrar Issa, MD, et al.
Published: (2025-09-01)

Presentation of A Case of Obstructive Jaundice Due to Fasciola hepatica
by: Amir Hooshang Mohammad Alizadeh, et al.
Published: (2000-12-01)

RESISTANCE OF Fasciola hepatica TO TRICLABENDAZOLE, CLOSANTEL, AND RAFOXANIDE IN A SHEEP FARM IN SHARAZOR DISTRICT, KURDISTAN-IRAQ
by: Fattah Marif Hardi, et al.
Published: (1970-01-01)

Brote epidémico de fascioliasis invasiva: Estudio de una familia
by: Gloria Astencio Rodríguez, et al.
Published: (2002-08-01)

Imported Human Fascioliasis, United Kingdom
by: Meera A. Chand, et al.
Published: (2009-11-01)

Seroprevalence of Human Fascioliasis in Chaharmahal and Bakhtiyari Province, Southwestern Iran
by: Kouroush MANOUCHEHRI NAEINI, et al.
Published: (2016-08-01)

Liver, spleen, pancreas and kidney involvement by human fascioliasis: imaging findings
by: Hekmatdoost Azita, et al.
Published: (2004-08-01)

Epidemiology of Human Fascioliasis in Iran
by: A.R Salahi moghadam
Published: (2009-09-01)

REPORT OF HUMAN FASCIOLIASIS UNDER DIFFERENT CLIMATIC CONDITIONS IN BRAZIL
by: Marcel Gonçalves Maciel, et al.
Published: (2023-05-01)

Evaluación de una prueba de ELISA con antígeno metabólico de Fasciola hepatica para el diagnóstico de fasciolosis humana en Cajamarca, Perú Evaluation of an ELISA test with Fasciola hepatica metabolic antigen for diagnosis of human fascioliasis in Cajamarca, Peru
by: Hernán Cornejo, et al.
Published: (2010-12-01)

The Effect of Triclabendazole on ALT Enzyme activity in Fasciola hepatica helminths and parasitized sheep liver tissues
by: Ali Farahnak, et al.
Published: (2015-01-01)

Drug potency effects of three anthelmintics against natural fascioliasis with hematological values in goat
by: Md. Ashraf Zaman Faruk
Published: (2023-03-01)

Estandarización de la técnica de Western blot para el diagnóstico de la fasciolosis humana utilizando antígenos de excreción-secreción de Fasciola hepática Western blot technique standardization of the diagnosis of human fasciolosis using Fasciola hepatica excreted-secreted antigens
by: Hermes Escalante, et al.
Published: (2011-09-01)

Biochemical and immunological investigation of fascioliasis in cattle in Egypt
by: Nani Nasreldin, et al.
Published: (2020-05-01)

MORPHOFUNCTIONAL PECULIARITIES OF FASCIOLA HEPATICA ORGANS CHANGES AFTER TREATMENT OF SHEEP WITH TRICLABENDAZOLE IN CASE OF FASCIOLOSIS
by: O. I. Bibik, et al.
Published: (2019-09-01)

Efficacy of flukicides against Fasciola hepatica and first report of triclabendazole resistance on German sheep farms
by: Alexandra Kahl, et al.
Published: (2023-12-01)

Clinical, laboratory features and treatment outcomes of patients infected with Fasciola in Northern Vietnam, 2019–2023
by: Nguyen Kim Thu, et al.
Published: (2025-08-01)

The Differences in the Susceptibility Patterns to Triclabendazole Sulfoxide in Field Isolates of <i>Fasciola hepatica</i> Are Associated with Geographic, Seasonal, and Morphometric Variations
by: Martha V. Fernandez-Baca, et al.
Published: (2022-05-01)

Application of a geographical information system approach for risk analysis of fascioliasis in southern Espírito Santo state, Brazil
by: Isabella Vilhena Freire Martins, et al.
Published: (2012-09-01)

Presencia de infestación por Fasciola hepatica en habitantes del valle de San Nicolás, oriente antioqueño Presence of infection by Fasciola hepatica in inhabitants from the valle de San Nicolás, eastern Antioquia
by: Christian Wilches, et al.
Published: (2009-06-01)

Fasciola hepatica Control Practices on a Sample of Dairy Farms in Victoria, Australia
by: Jane M. Kelley, et al.
Published: (2021-06-01)

Clonal amplification of Fasciola hepatica in Galba truncatula: within and between isolate variation of triclabendazole-susceptible and -resistant clones
by: Jane E. Hodgkinson, et al.
Published: (2018-06-01)

Aspects of the Maintenance of the Life Cycle of Fasciola hepatica in Lymnaea columella in Minas Gerais, Brazil
by: Souza Cecília Pereira de, et al.
Published: (2002-01-01)

Estudio clínico epidemiológico de la fascioliasis hepática en la provincia de Ciego Avila. Cuba
by: J. Camacho, et al.
Published: (1996-09-01)

Biliary fascioliasis – A rare differential diagnosis of biliary obstruction
by: Phuong Anh Ton Nu, et al.
Published: (2022-10-01)

FASCIOLA HEPATICA: MORPHOMETRIC ANALYSIS OF EGGS AFTER TRICLABENDAZOLE TREATMENT
by: OKSANA I. Bibik, et al.
Published: (2018-06-01)

Transcriptional analysis identifies key genes involved in metabolism, fibrosis/tissue repair and the immune response against Fasciola hepatica in sheep liver
by: Cristian A Alvarez Rojas, et al.
Published: (2015-02-01)

Peri Cholecystectomy Bile Analysis for Fasciola hepatica Eggs in Sulaimani Teaching Hospital
by: Seerwan Hama Shareef, et al.
Published: (2019-10-01)

Peri Cholecystectomy Bile Analysis for Fasciola hepatica Eggs in Sulaimani Teaching Hospital
by: Seerwan Hama Shareef, et al.
Published: (2019-10-01)

Study of triclabendazole effects on <i>Fasciola hepatica’</i>s life-supporting organs, spines and suckers responsible for stable position of the parasite in the host
by: O. I. Bibik, et al.
Published: (2021-09-01)

Immunodiagnosis of cattle fascioliasis using a 27 kDa Fasciola gigantica antigen
by: Mohamed J. Saadh, et al.
Published: (2021-08-01)

Conocimientos, actitudes y prácticas sobre fascioliasis en madres de una zona rural andina del norte peruano Knowledge, attitudes and practices about fascioliasis among mothers from an andean rural area of north Peru
by: Marco Rivera-Jacinto, et al.
Published: (2010-03-01)

Distinct gut microbiome features characterize Fasciola hepatica infection and predict triclabendazole treatment outcomes in Peruvian patients
by: Giljae Lee, et al.
Published: (2025-03-01)

Imported fascioliasis in non-endemic countries: a case series and review of the literature
by: Paola Rodari, et al.
Published: (2025-09-01)

High Efficacy of Triclabendazole/Ivermectin Combination Compared to Triclabendazole Monotherapy for Treating Human Fascioliasis in Upper Egypt: A Prospective Study
by: Waleed Attia Hassan, et al.
Published: (2025-08-01)

Evidence Suggesting that Fasciola gigantica Might be the Most Prevalent Causal Agent of Fascioliasis in Northern Iran
by: K Ashrafi, et al.
Published: (2004-12-01)